Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
Name / Ticker | Price | Zen Rating |
---|---|---|
$3.36 | A | |
$9.07 | A | |
$18.91 | A |